- Report
- December 2023
- 200 Pages
Global
From €2356EUR$2,450USD£2,021GBP
- Report
- October 2023
- 193 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 181 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 186 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- June 2023
- 120 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- March 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 250 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- December 2023
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- December 2023
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- December 2023
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- November 2023
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 149 Pages
Global
From €3749EUR$3,899USD£3,216GBP
- Report
- April 2024
- 180 Pages
Global
From €4712EUR$4,900USD£4,042GBP
The Communicable Disease Control market is a subset of the Infectious Disease Testing market, focusing on the prevention, diagnosis, and treatment of communicable diseases. This market includes products and services such as diagnostic tests, vaccines, and therapeutics. Diagnostic tests are used to detect the presence of a communicable disease, while vaccines are used to prevent the spread of communicable diseases. Therapeutics are used to treat communicable diseases.
The Communicable Disease Control market is driven by the increasing prevalence of communicable diseases, the growing demand for rapid and accurate diagnosis, and the increasing availability of vaccines. Additionally, the increasing focus on public health initiatives and the development of new technologies are expected to drive the market.
Some companies in the Communicable Disease Control market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more